| scholarly article | Q13442814 |
| P50 | author | Trevor W. Robbins | Q7839400 |
| Timothy Rittman | Q57159047 | ||
| Laura E Hughes | Q56941567 | ||
| James B. Rowe | Q24265625 | ||
| Ralf Regenthal | Q44746190 | ||
| P2860 | cites work | Neuropsychological features of patients with Parkinson’s disease and impulse control disorders | Q59153398 |
| [Stereotyped behaviors and compulsive complaints of pain improved by fluvoxamine in two cases of frontotemporal dementia] | Q79617995 | ||
| The key locus of common response inhibition network for no-go and stop signals | Q80783527 | ||
| Mapping motor inhibition: conjunctive brain activations across different versions of go/no-go and stop tasks. | Q49065336 | ||
| In vivo imaging of serotonin transporter occupancy by means of SPECT and [123I]ADAM in healthy subjects administered different doses of escitalopram or citalopram. | Q50223962 | ||
| Serotonergic function and treatment of behavioral and psychological symptoms of frontotemporal dementia. | Q50994570 | ||
| The functional 5-HT1A receptor polymorphism affects response inhibition processes in a context-dependent manner. | Q51865038 | ||
| Impulsiveness and ERP components in a Go/Nogo task. | Q51892461 | ||
| Frontal assessment battery and differential diagnosis of frontotemporal dementia and Alzheimer disease. | Q51939038 | ||
| Movement-related potentials in the Go/NoGo task: the P3 reflects both cognitive and motor inhibition. | Q51968192 | ||
| Comparison of inhibitory functioning in mild Alzheimer's disease and frontotemporal dementia. | Q51974907 | ||
| Individual differences discriminate event-related potentials but not performance during response inhibition. | Q52968510 | ||
| Frontotemporal Dementia | Q56388061 | ||
| Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia | Q24598142 | ||
| Automated Anatomical Labeling of Activations in SPM Using a Macroscopic Anatomical Parcellation of the MNI MRI Single-Subject Brain | Q25855787 | ||
| 'It's the way that you look at it'--a cognitive neuropsychological account of SSRI action in depression | Q26824072 | ||
| Fluoxetine, but not other selective serotonin uptake inhibitors, increases norepinephrine and dopamine extracellular levels in prefrontal cortex | Q28210946 | ||
| A fast diffeomorphic image registration algorithm | Q28243996 | ||
| An automated method for neuroanatomic and cytoarchitectonic atlas-based interrogation of fMRI data sets | Q29614928 | ||
| Inhibition and the right inferior frontal cortex | Q29615934 | ||
| The impact of neurodegeneration on network connectivity: a study of change detection in frontotemporal dementia | Q30452411 | ||
| Parkinson's disease and dopaminergic therapy--differential effects on movement, reward and cognition | Q30482965 | ||
| Scanning patients with tasks they can perform. | Q30582749 | ||
| Inhibition and the right inferior frontal cortex: one decade on. | Q30736796 | ||
| Psychological, neuroimaging, and biochemical studies on functional association between impulsive behavior and the 5-HT2A receptor gene polymorphism in humans | Q31087719 | ||
| Shifting and stopping: fronto-striatal substrates, neurochemical modulation and clinical implications | Q33281324 | ||
| Impulse control disorders in Parkinson disease: a cross-sectional study of 3090 patients | Q33574373 | ||
| Inhibitory motor control in stop paradigms: review and reinterpretation of neural mechanisms | Q33645226 | ||
| Atrophy patterns in histologic vs clinical groupings of frontotemporal lobar degeneration. | Q33682545 | ||
| Measuring disease progression in frontotemporal lobar degeneration: a clinical and MRI study. | Q33698184 | ||
| The FAB: a Frontal Assessment Battery at bedside. | Q33927821 | ||
| Stop-signal inhibition disrupted by damage to right inferior frontal gyrus in humans. | Q34171615 | ||
| Frontotemporal dementia: treatment response to serotonin selective reuptake inhibitors | Q34428922 | ||
| TDP-43 subtypes are associated with distinct atrophy patterns in frontotemporal dementia | Q34455599 | ||
| Performance on the Frontal Assessment Battery is sensitive to frontal lobe damage in stroke patients | Q34478445 | ||
| Frontal paralimbic network atrophy in very mild behavioral variant frontotemporal dementia | Q34749217 | ||
| Inverted-U-shaped dopamine actions on human working memory and cognitive control | Q35035569 | ||
| Magnetoencephalography of frontotemporal dementia: spatiotemporally localized changes during semantic decisions | Q35206966 | ||
| A systematic review of neurotransmitter deficits and treatments in frontotemporal dementia | Q35844609 | ||
| PharmGKB summary: citalopram pharmacokinetics pathway | Q35952370 | ||
| Serotonin 2A receptors, citalopram and tryptophan-depletion: a multimodal imaging study of their interactions during response inhibition | Q36775232 | ||
| Frontotemporal dementia: recommendations for therapeutic studies, designs, and approaches | Q36806674 | ||
| Serotoninergic regulation of emotional and behavioural control processes | Q37028037 | ||
| Frontotemporal dementia treatment: current symptomatic therapies and implications of recent genetic, biochemical, and neuroimaging studies | Q37036238 | ||
| Voxel-based morphometry patterns of atrophy in FTLD with mutations in MAPT or PGRN | Q37180625 | ||
| The neuropsychopharmacology of action inhibition: cross-species translation of the stop-signal and go/no-go tasks | Q37187494 | ||
| Multiple modes of impulsivity in Parkinson's disease | Q37499687 | ||
| Selective serotonin reuptake inhibition modulates response inhibition in Parkinson's disease | Q37647815 | ||
| Serotonin and dopamine: unifying affective, activational, and decision functions | Q37782264 | ||
| Nonprogressive behavioural frontotemporal dementia: recent developments and clinical implications of the 'bvFTD phenocopy syndrome'. | Q37801816 | ||
| Inhibitory dysfunction in frontotemporal dementia: a review | Q38029204 | ||
| Electroencephalography of response inhibition tasks: functional networks and cognitive contributions | Q38036028 | ||
| Parkinson's disease, the subthalamic nucleus, inhibition, and impulsivity | Q38258234 | ||
| Neural correlates of semantic and behavioural deficits in frontotemporal dementia | Q38417601 | ||
| Abnormal network connectivity in frontotemporal dementia: evidence for prefrontal isolation | Q38462228 | ||
| Serotonin neuron loss and nonmotor symptoms continue in Parkinson's patients treated with dopamine grafts | Q39249440 | ||
| Precentral gyrus discrepancy in electronic versions of the Talairach atlas. | Q39674495 | ||
| Acute citalopram administration may disrupt contextual information processing in healthy males | Q39953704 | ||
| The effect of acute tryptophan depletion on the BOLD response during performance monitoring and response inhibition in healthy male volunteers | Q40324001 | ||
| Is inhibitory control a 'no-go' in adolescents with autism spectrum disorder? | Q41989034 | ||
| Serotonin modulates sensitivity to reward and negative feedback in a probabilistic reversal learning task in rats | Q42682244 | ||
| Staging of serotonergic dysfunction in Parkinson's disease: an in vivo 11C-DASB PET study | Q42994792 | ||
| Reorganisation of brain networks in frontotemporal dementia and progressive supranuclear palsy. | Q43096897 | ||
| Are the neural correlates of stopping and not going identical? Quantitative meta-analysis of two response inhibition tasks | Q43451906 | ||
| Frontotemporal dementia: evidence for impairment of ascending serotoninergic but not noradrenergic innervation. Immunocytochemical and quantitative study using a graph method | Q43578731 | ||
| Altered serotonergic and cholinergic synaptic markers in Pick's disease | Q44008196 | ||
| 5-HT(2C) receptor activation by m-chlorophenylpiperazine detected in humans with fMRI. | Q44129906 | ||
| Frontotemporal dementia: paroxetine as a possible treatment of behavior symptoms. A randomized, controlled, open 14-month study | Q44237719 | ||
| Quantitative microdialysis using modified ultraslow microdialysis: direct rapid and reliable determination of free brain concentrations with the MetaQuant technique. | Q44436805 | ||
| Significance testing of difference potentials | Q44485627 | ||
| Paroxetine does not improve symptoms and impairs cognition in frontotemporal dementia: a double-blind randomized controlled trial. | Q44687049 | ||
| Efficacy of fluvoxamine as a treatment for behavioral symptoms in frontotemporal lobar degeneration patients | Q44739300 | ||
| Frontotemporal dementia: a randomised, controlled trial with trazodone | Q44922723 | ||
| The selective serotonin reuptake inhibitor citalopram increases fear after acute treatment but reduces fear with chronic treatment: a comparison with tianeptine | Q44926896 | ||
| Functional and effective connectivity of stopping | Q45194571 | ||
| Glucose metabolism and serotonin receptors in the frontotemporal lobe degeneration. | Q45237155 | ||
| Response inhibition in Huntington's disease-a study using ERPs and sLORETA. | Q45288632 | ||
| The utility of the Cambridge Behavioural Inventory in neurodegenerative disease. | Q45306346 | ||
| Stereotypical movements and frontotemporal dementia. | Q45935141 | ||
| Altered brain concentrations of citalopram and escitalopram in P-glycoprotein deficient mice after acute and chronic treatment. | Q45988855 | ||
| Combined magnetic resonance imaging and positron emission tomography brain imaging in behavioural variant frontotemporal degeneration: refining the clinical phenotype. | Q46024825 | ||
| Serotonin depletion impairs waiting but not stop-signal reaction time in rats: implications for theories of the role of 5-HT in behavioral inhibition | Q46250019 | ||
| The effect of citalopram pretreatment on neuronal responses to neuropsychological tasks in normal volunteers: an FMRI study | Q46435454 | ||
| Tryptophan depletion reduces right inferior prefrontal activation during response inhibition in fast, event-related fMRI. | Q46484986 | ||
| Imbalance of a serotonergic system in frontotemporal dementia: implication for pharmacotherapy | Q46890765 | ||
| Serotonergic modulation of neuronal responses to behavioural inhibition and reinforcing stimuli: an fMRI study in healthy volunteers | Q46899532 | ||
| Serotonin-1A receptors in frontotemporal dementia compared with controls. | Q46919210 | ||
| Response inhibition in adults and teenagers: spatiotemporal differences in the prefrontal cortex | Q46978186 | ||
| Electrophysiological correlates of anterior cingulate function in a go/no-go task: effects of response conflict and trial type frequency | Q47809803 | ||
| Spatiotemporal characterization of response inhibition. | Q48113322 | ||
| Conflict and inhibition in the cued-Go/NoGo task. | Q48126734 | ||
| Neurochemical features of frontotemporal dementia | Q48143141 | ||
| A multiple source approach to the correction of eye artifacts | Q48171021 | ||
| Common inhibitory mechanism in human inferior prefrontal cortex revealed by event-related functional MRI. | Q48194617 | ||
| Fronto-striatal atrophy correlates of inhibitory dysfunction in Parkinson's disease versus behavioural variant frontotemporal dementia | Q48217290 | ||
| Conflict and inhibition differentially affect the N200/P300 complex in a combined go/nogo and stop-signal task | Q48226449 | ||
| Central serotonin depletion impairs both the acquisition and performance of a symmetrically reinforced go/no-go conditional visual discrimination | Q48231322 | ||
| Sequence effects support the conflict theory of N2 and P3 in the Go/NoGo task. | Q48243674 | ||
| No-go dominant brain activity in human inferior prefrontal cortex revealed by functional magnetic resonance imaging. | Q48386794 | ||
| Standardized low-resolution brain electromagnetic tomography (sLORETA): technical details. | Q48392610 | ||
| Neuroanatomical correlates of behavioural phenotypes in behavioural variant of frontotemporal dementia. | Q48405837 | ||
| Motor and non-motor inhibition in the Go/NoGo task: an ERP and fMRI study. | Q48412061 | ||
| The Addenbrooke's Cognitive Examination Revised (ACE-R): a brief cognitive test battery for dementia screening. | Q48420549 | ||
| Inhibition, conflict and the Nogo-N2. | Q48487919 | ||
| The N2 in go/no-go tasks reflects conflict monitoring not response inhibition. | Q48515567 | ||
| Functional genetic variation in the serotonin 5-HTTLPR modulates brain damage in frontotemporal dementia. | Q48601704 | ||
| Executive "brake failure" following deactivation of human frontal lobe. | Q48630574 | ||
| Event-related potentials for response inhibition in Parkinson's disease. | Q49041471 | ||
| P433 | issue | Pt 7 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | frontotemporal dementia | Q18592 |
| P304 | page(s) | 1961-1975 | |
| P577 | publication date | 2015-05-21 | |
| P1433 | published in | Brain | Q897386 |
| P1476 | title | Improving response inhibition systems in frontotemporal dementia with citalopram | |
| P478 | volume | 138 |
| Q47322264 | Apathy and impulsivity in frontotemporal lobar degeneration syndromes. |
| Q26772944 | Clinical Approach to Progressive Supranuclear Palsy |
| Q90591149 | Development of disease-modifying drugs for frontotemporal dementia spectrum disorders |
| Q40048388 | Event-related fields evoked by vocal response inhibition: a comparison of younger and older adults. |
| Q46742934 | Fair play: social norm compliance failures in behavioural variant frontotemporal dementia |
| Q38827166 | First Symptoms and Neurocognitive Correlates of Behavioral Variant Frontotemporal Dementia. |
| Q49430878 | Frontotemporal dementia: latest evidence and clinical implications. |
| Q36159464 | Grey and White Matter Clinico-Anatomical Correlates of Disinhibition in Neurodegenerative Disease |
| Q38917764 | Inappropriate behaviors and hypersexuality in individuals with dementia: An overview of a neglected issue |
| Q39017916 | Managing cognition in progressive supranuclear palsy. |
| Q52344625 | Neuroimmune Tau Mechanisms: Their Role in the Progression of Neuronal Degeneration. |
| Q90399950 | Neuroinflammation as a Common Feature of Neurodegenerative Disorders |
| Q61718876 | Neurophysiological signatures of Alzheimer's disease and frontotemporal lobar degeneration: pathology versus phenotype |
| Q47837913 | Neurotransmitter deficits from frontotemporal lobar degeneration |
| Q38738414 | Pharmacological Management of Psychiatric Symptoms in Frontotemporal Dementia: A Systematic Review |
| Q36762203 | Predicting beneficial effects of atomoxetine and citalopram on response inhibition in Parkinson's disease with clinical and neuroimaging measures |
| Q64218022 | Reorganization of cortical oscillatory dynamics underlying disinhibition in frontotemporal dementia |
| Q38737187 | Serotonergic drugs for the treatment of neuropsychiatric symptoms in dementia |
| Q48091480 | The Neuropsychology (Broadly Conceived) of Multiple System Atrophy, Progressive Supranuclear Palsy, and Corticobasal Degeneration |
| Q60050592 | The neuroanatomical and neurochemical basis of apathy and impulsivity in frontotemporal lobar degeneration |
| Q64102453 | Toward a Glutamate Hypothesis of Frontotemporal Dementia |
Search more.